Key facts
- Tocu’s last known valuation is $2.0M (Feb 2026).
- It has raised $340K; the latest was Early Stage VC ($340K) in Feb 2026.
- Notable investors include SFC Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Tocu
- ·The full record, as it builds
Funding rounds
No funding rounds for Tocu are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Tocu
Manufacturer of transdermal vitamin patches designed to deliver nutrients through the skin as an alternative to oral supplements. The company produces adhesive wellness patches formulated with vitamins, minerals, and botanical extracts that bypass the digestive system and release nutrients directly into the bloodstream, enabling consumers to support energy, sleep, immunity, and general wellness through wearable supplement delivery.
- Sector
- Consumer Products and Services (B2C)
- HQ
- London, United Kingdom
- Founded
- 2023
- Employees
- 1
- Website
- tocuhealth.com/
- Ownership
- Privately Held (backing)
Tocu doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Tocu shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Tocu in its N-PORT filings yet. We sweep new filings monthly.